Sunovion Pharmaceuticals Inc.
1455 Pennsylvania Avenue, NW, Suite 1000
Washington DC 20004
Sunovion Pharmaceuticals Inc. is a research-based pharmaceutical company dedicated to discovering, developing and commercializing scientifically advanced therapeutic products that are focused on helping patients suffering from central nervous system and respiratory disorders, as well as other illnesses. A wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd., Sunovion was formed following the merger of DSP's two U.S.-based operations, Sepracor Inc. and Dainippon Sumitomo Pharma America, Inc. The company name, which is representative of the life-affirming energy of the sun and the power of innovation, reflects Sunovion's portfolio of currently marketed pharmaceutical products and pipeline candidates; and serves to emphasize the company's ongoing commitment to improve the lives of patients everywhere.
Powered By GrowthZone